Midazolam Premedication Facilitates Mask Ventilation During Induction of General Anesthesia: A Randomized Clinical Trial

Anesth Analg. 2019 Aug;129(2):500-506. doi: 10.1213/ANE.0000000000003707.

Abstract

Background: During induction of general anesthesia, proper mask ventilation is crucial for supplying sufficient oxygen to unconscious patients. Midazolam has a relaxing effect on airway muscles. We hypothesized that sedative premedication with midazolam would facilitate mask ventilation during anesthetic induction.

Methods: Patients undergoing elective surgery under general anesthesia were randomized into 2 groups. The midazolam group received midazolam premedication at the reception area, 3 minutes before transfer to the operating room. Patients in the control group were treated with normal saline as a placebo. The primary outcome was difficulty of mask ventilation during induction, as evaluated using the Warters scales.

Results: A total of 97 patients completed the analysis: 49 in the control group and 48 in the midazolam group. The patients in the midazolam group showed a significantly lower mask ventilation difficulty score on the Warters scale than that of the control group (mean [standard deviation], 0.92 [1.13] vs 0.19 [0.57]; estimated difference [95% confidence interval], 0.73 [0.37-1.09]; P < .001). The incidence of difficult mask ventilation (≥2 Warters scale) was significantly lower in the midazolam group than in the control group (risk ratio [95% confidence interval], 0.15 [0.03-0.72]; P = .015).

Conclusions: This randomized clinical trial demonstrated that midazolam premedication enhanced mask ventilation during induction of general anesthesia.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Anesthesia, General / adverse effects
  • Anesthesia, General / instrumentation*
  • Drug Administration Schedule
  • Equipment Design
  • Female
  • Humans
  • Male
  • Midazolam / administration & dosage*
  • Midazolam / adverse effects
  • Middle Aged
  • Neuromuscular Agents / administration & dosage*
  • Neuromuscular Agents / adverse effects
  • Premedication* / adverse effects
  • Respiration, Artificial / adverse effects
  • Respiration, Artificial / instrumentation*
  • Seoul
  • Time Factors
  • Treatment Outcome
  • Young Adult

Substances

  • Neuromuscular Agents
  • Midazolam

Associated data

  • CRiS/KCT0002323